spacer
home > ebr > autumn 2009 > designer therapeutic proteins
PUBLICATIONS

 

Dear guest!
To access full content of this article, please take a minute to become a member of this site. As a registered user you will be able to view all of our vast archive's material at any time. Sign up now!

       Already registered? Please sign in.

Alternatively, please use our pay-per-view service.

spacer

 
News and Press Releases

Abzena hires Matthew Stober to lead the company through the next phase of global growth

San Diego, CA, 10th January 2023 Abzena, the leading end-to-end integrated CDMO for Antibody Drug Conjugates (ADCs) and complex biologic molecules, announced today that Matthew Stober has joined as their new Chief Executive Officer.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement